» Articles » PMID: 2031875

Protective Effects of Propionyl-L-carnitine During Ischemia and Reperfusion

Overview
Date 1991 Feb 1
PMID 2031875
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

When cardiac function in isolated rat hearts was impaired by subjecting them to ischemia, subsequent perfusion with propionyl-L-carnitine and related compounds increased their rate of recovery. Thus at 11 mM, both propionyl-L-carnitine and, to a lesser extent, its taurine amide, and also acetyl-L-carnitine, significantly restored cardiac function in 15 minutes after 90 minutes of either low-flow or intermittent no-flow ischemia. Carnitine itself was ineffective. Propionyl-L-carnitine also increased tissue ATP and creatine phosphate compared with controls, but did not affect the levels of long-chain acyl carnitine and coenzyme. These esters also depleted fatty acid peroxidation, as shown with malonaldehyde, and were more effective than carnitine in preventing the production of superoxide. In myocytes, propionyl-L-carnitine alone stimulated palmitate oxidation, but in rat heart homogenates, both L-carnitine and propionyl-L-carnitine did so, while acetyl-L-carnitine was actually inhibitory. Possible mechanisms for the protective action of propionyl-L-carnitine against ischemia include an increased rate of cellular transport, stimulation of fatty acid oxidation, and a reduction of free radical formation.

Citing Articles

Targeting Skeletal Muscle Dysfunction With L-Carnitine for the Treatment of Patients With Chronic Obstructive Pulmonary Disease.

Hoang B, Han B, Fang W, Nguyen A, Shaw D, Hoang C In Vivo. 2023; 37(4):1399-1411.

PMID: 37369514 PMC: 10347949. DOI: 10.21873/invivo.13224.


Effects of propionyl-L-carnitine on ischemia-reperfusion injury in hamster cheek pouch microcirculation.

Lapi D, Sabatino L, Altobelli G, Mondola P, Cimini V, Colantuoni A Front Physiol. 2011; 1:132.

PMID: 21423374 PMC: 3059950. DOI: 10.3389/fphys.2010.00132.


L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions.

Loster H, Bohm U Mol Cell Biochem. 2001; 217(1-2):83-90.

PMID: 11269669 DOI: 10.1023/a:1007255021484.


Propionyl-L-carnitine.

Wiseman L, Brogden R Drugs Aging. 1998; 12(3):243-8; discussion 249-50.

PMID: 9534023 DOI: 10.2165/00002512-199812030-00006.


Differential mechanism of block of palmitoyl lysophosphatidylcholine and of palmitoylcarnitine on inward rectifier K+ channels of guinea-pig ventricular myocytes.

Sato T, Arita M, Kiyosue T Cardiovasc Drugs Ther. 1993; 7 Suppl 3:575-84.

PMID: 8251427 DOI: 10.1007/BF00877623.


References
1.
Hearse D, Shattock M, Manning A, Braimbridge M . Protection of the myocardium during ischemic arrest: possible toxicity of carnitine in cardioplegic solutions. Thorac Cardiovasc Surg. 1980; 28(4):253-8. DOI: 10.1055/s-2007-1022090. View

2.
Turrens J, Alexandre A, Lehninger A . Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys. 1985; 237(2):408-14. DOI: 10.1016/0003-9861(85)90293-0. View

3.
Molstad P . The efflux of L-carnitine from cells in culture (CCL 27). Biochim Biophys Acta. 1980; 597(1):166-73. DOI: 10.1016/0005-2736(80)90160-1. View

4.
Shug A, Subramanian R . Modulation of adenine nucleotide translocase activity during myocardial ischemia. Z Kardiol. 1987; 76 Suppl 5:26-33. View

5.
Kamikawa T, Suzuki Y, Kobayashi A, Hayashi H, MASUMURA Y, Nishihara K . Effects of L-carnitine on exercise tolerance in patients with stable angina pectoris. Jpn Heart J. 1984; 25(4):587-97. DOI: 10.1536/ihj.25.587. View